Lv3
392 积分 2022-09-16 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
1天前
待确认
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
1天前
已完结
A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China
26天前
已关闭
Reconsidering OCD pharmacotherapy: The case for levomilnacipran as a safer alternative to clomipramine
27天前
已关闭
Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7–17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies
27天前
已完结
Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis
1个月前
已完结
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial
1个月前
已完结
Pretomanid for the treatment of drug resistant pulmonary tuberculosis: a comprehensive review
1个月前
已完结
Pretomanid: The latest USFDA-approved anti-tuberculosis drug
1个月前
已完结
Pretomanid: First Approval
1个月前
已完结
皖公网安备34019202002308
